Kim, H., Kim, I., Kim, J., Kim, T., Hyung, J., Lee, I., Lee, H. H., Park, Y. S., Lee, J. S., Ryu, M. (2026). Multicenter phase Ib/II study of neoadjuvant zolbetuximab plus docetaxel, oxaliplatin, and S-1 (DOS) followed by adjuvant zolbetuximab/S-1 in patients with CLDN18.2-positive resectable gastric or gastroesophageal junction adenocarcinoma (NEOCLAUD).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps4250